Proteomics

Dataset Information

0

SIRT6 phosphorylation - MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer


ABSTRACT: Sirtuin 6 (SIRT6) is associated with longevity and was recently established as a tumor suppressor. Hence, identifying the molecular regulators of SIRT6 might enable its activation therapeutically in cancer patients. We found that SIRT6 was phosphorylated by the kinase AKT1 at Ser338, which induces its interaction with and ubiquitination by MDM2, priming it for protease-dependent degradation. The survival of patients with breast cancers positively correlated with the abundance of SIRT6 and inversely correlated with the phosphorylation of SIRT6 at Ser338. In a large panel of breast tumor biopsies, SIRT6 abundance inversely correlated with the abundance of phosphorylated AKT. Inhibiting AKT or preventing SIRT6 phosphorylation by mutating Ser338 prevented the degradation of SIRT6 mediated by MDM2, suppressed the proliferation of breast cancer cells in culture, and inhibited the growth of breast tumor xenografts in mice. Overexpressing MDM2 decreased the abundance of SIRT6 in cells, whereas overexpressing an E3 ligase-deficient MDM2 or knocking down endogenous MDM2 increased SIRT6 abundance. Knocking down SIRT6 decreased the sensitivity of a breast cancer cell line to trastuzumab, whereas overexpression of a non-phosphorylatable SIRT6 mutant increased trastuzumab sensitivity in a resistant subculture. Thus, stabilizing SIRT6 may be a clinical strategy for overcoming trastuzumab resistance in breast cancer patients.

INSTRUMENT(S): Q TRAP

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell, Hela Cell

DISEASE(S): Breast Cancer

SUBMITTER: Umadevi Thirumurthi  

LAB HEAD: Mien-Chie Hung

PROVIDER: PXD001154 | Pride | 2016-07-06

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Flag-SIRT6-P-p.msm Other
Flag-SIRT6-P-p.raw Raw
SIRT6-S330-p.jpg Other
SIRT6-p.xml Xml
flag-SIRT6-S303-MSMS.jpg Other
Items per page:
1 - 5 of 6
altmetric image

Publications

MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer.

Thirumurthi Umadevi U   Shen Jia J   Xia Weiya W   LaBaff Adam M AM   Wei Yongkun Y   Li Chia-Wei CW   Chang Wei-Chao WC   Chen Chung-Hsuan CH   Lin Hui-Kuan HK   Yu Dihua D   Hung Mien-Chie MC  

Science signaling 20140729 336


Sirtuin 6 (SIRT6) is associated with longevity and is also a tumor suppressor. Identification of molecular regulators of SIRT6 might enable its activation therapeutically in cancer patients. In various breast cancer cell lines, we found that SIRT6 was phosphorylated at Ser(338) by the kinase AKT1, which induced the interaction and ubiquitination of SIRT6 by MDM2, targeting SIRT6 for protease-dependent degradation. The survival of breast cancer patients positively correlated with the abundance of  ...[more]

Similar Datasets

2017-02-09 | GSE75905 | GEO
2023-12-31 | GSE216185 | GEO
2023-12-31 | GSE216183 | GEO
2010-06-24 | E-GEOD-13272 | biostudies-arrayexpress
2016-04-01 | E-GEOD-79503 | biostudies-arrayexpress
2022-10-21 | PXD035689 | Pride
2010-06-08 | E-GEOD-21965 | biostudies-arrayexpress
2010-05-28 | GSE21965 | GEO
2017-12-21 | GSE104161 | GEO
2024-01-31 | GSE236460 | GEO